TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Invion ( (AU:IVX) ) just unveiled an announcement.
Invion Limited’s Annual General Meeting highlighted its commitment to advancing next-generation photodynamic therapy (PDT) for cancers and infectious diseases. This strategic focus aims to enhance the company’s position in the biotechnology sector by addressing critical health challenges, potentially impacting stakeholders by offering innovative treatment solutions.
More about Invion
Invion Limited operates in the biotechnology industry, focusing on developing next-generation photodynamic therapy (PDT) for treating cancers and infectious diseases.
YTD Price Performance: -71.79%
Average Trading Volume: 76,662
Technical Sentiment Signal: Sell
Current Market Cap: A$6.77M
See more insights into IVX stock on TipRanks’ Stock Analysis page.